ResearcherChanghai HospitalActive in the last 2 years
Pingping Zhang
Matched on OpenAlex author ID A5147394922. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2024: 2 papers · 2025: 1 paper
Papers 3
- Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer. Co-author DOI 10.1186/s12885-025-14096-x↗
- SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. Co-author DOI 10.1016/j.canlet.2024.216733↗
- Clinical efficacy of EUS-guided celiac plexus neurolysis versus EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain relief in advanced pancre… Co-author DOI 10.1097/eus.0000000000000048↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xianbin Zhang · 2 shared papers, 2024–2025 · strength 0.51
- Paper Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancr… DOI 10.1186/s12885-025-14096-x↗
- Paper SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. DOI 10.1016/j.canlet.2024.216733↗
- Jiahui Yuan · 2 shared papers, 2024–2025 · strength 0.51
- Paper Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancr… DOI 10.1186/s12885-025-14096-x↗
- Paper SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. DOI 10.1016/j.canlet.2024.216733↗
- Yongcheng Su · 1 shared paper, 2025 · strength 0.30
- Peng Gong · 1 shared paper, 2025 · strength 0.30
- Kaixuan Wang · 1 shared paper, 2024 · strength 0.22
- Milad Ashrafizadeh · 1 shared paper, 2024 · strength 0.21
- Peng Gong · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.